Fewer Drug Plan Choices: Capitalism's Cure for Your Old Age
According to the Associated Press , the number of standalone Medicare Part D prescription plans available to seniors is plummeting, down from nearly 30 in 2021 to 8-12 for 2026. Experts cite the Inflation Reduction Act's cap on out-of-pocket drug costs at $2,100 as 'financial pressure' on insurers. It seems providing affordable medication, through legislation signed by President Biden, is simply
too taxing for these benevolent corporations. While insurers like Elevance exit the market (a 'tough business' when you can't price gouge indefinitely), one might wonder about the 'financial pressure' on the 23 million seniors relying on these plans. Perhaps their shrinking coverage options are just another innovative way for the private sector to 'streamline' healthcare, ensuring only the most
resilient (and richest) survive to enjoy their golden years. What's a little less choice when profits are at stake?